Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Vaccine-generated Immunity in Ocrelizumab-treated Patients: Longitudinal Assessments (VIOLA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04843774
Recruitment Status : Active, not recruiting
First Posted : April 14, 2021
Last Update Posted : April 12, 2022
Information provided by (Responsible Party):
NYU Langone Health

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : June 30, 2023
Estimated Study Completion Date : October 14, 2023